Calprotectin ‘most useful’ biomarker for IBD during COVID-19

A presenter at the Crohn’s and Colitis Congress highlighted the importance of biomarkers in determining disease activity in inflammatory bowel disease, especially in the era of COVID-19.“Calprotectin is the most useful biomarker available certainly for the current COVID-19 pandemic but absolutely also beyond the pandemic,” Britta Siegmond, Dr. Med, from Charité, Berlin University of Medicine, said during her presentation.One recent study showed calprotectin was a good biomarker when evaluating calprotectin in ulcerative colitis. Another study evaluated different typesRead More

Share on facebook
Share on twitter
Share on linkedin